Clomipramine-induced	clomipramine-induced	O	O	O	O
sleep	sleep	O	O	OTHERS	I
disturbance	disturbance	O	O	OTHERS	I
does	does	O	O	O	O
not	not	O	O	O	O
impair	impair	O	O	O	O
its	its	O	O	O	O
prolactin-releasing	prolactin-releasing	O	O	O	O
action	action	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
undertaken	undertaken	O	O	O	O
to	to	O	O	O	O
examine	examine	O	O	O	O
the	the	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
sleep	sleep	O	O	OTHERS	I
disturbance	disturbance	O	O	OTHERS	I
,	,	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
clomipramine	clomipramine	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
,	,	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
secretory	secretory	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
prolactin	prolactin	O	O	O	O
(	(	O	O	O	O
PRL	prl	O	O	OTHERS	I
)	)	O	O	O	O
in	in	O	O	O	O
addition	addition	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
direct	direct	O	O	O	O
drug	drug	O	O	O	O
effect	effect	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
groups	groups	O	O	O	O
of	of	O	O	O	O
supine	supine	O	O	O	O
subjects	subjects	O	O	O	O
were	were	O	O	O	O
studied	studied	O	O	O	O
under	under	O	O	O	O
placebo-controlled	placebo-controlled	O	O	O	O
conditions	conditions	O	O	O	O
,	,	O	O	O	O
one	one	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
night	night	O	O	O	O
,	,	O	O	O	O
when	when	O	O	O	O
sleeping	sleeping	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
7	7	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
at	at	O	O	O	O
daytime	daytime	O	O	O	O
,	,	O	O	O	O
when	when	O	O	O	O
awake	awake	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
6	6	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Each	each	O	O	O	O
subject	subject	O	O	O	O
received	received	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
50	50	O	O	O	O
mg	mg	O	O	OTHERS	I
dose	dose	O	O	O	O
of	of	O	O	O	O
clomipramine	clomipramine	CHEMICALS	O	OTHERS	I
given	given	O	O	O	O
orally	orally	O	O	O	O
2	2	O	O	O	O
hours	hours	O	O	O	O
before	before	O	O	O	O
blood	blood	O	O	O	O
collection	collection	O	O	O	O
.	.	O	O	O	O

Plasma	plasma	O	O	O	O
PRL	prl	O	O	OTHERS	I
concentrations	concentrations	O	O	O	O
were	were	O	O	O	O
analysed	analysed	O	O	O	O
at	at	O	O	O	O
10	10	O	O	O	O
min	min	O	O	O	O
intervals	intervals	O	O	O	O
and	and	O	O	O	O
underlying	underlying	O	O	O	O
secretory	secretory	O	O	O	O
rates	rates	O	O	O	O
calculated	calculated	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
deconvolution	deconvolution	O	O	O	O
procedure	procedure	O	O	O	O
.	.	O	O	O	O

For	for	O	O	O	O
both	both	O	O	O	O
experiments	experiments	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
intake	intake	O	O	O	O
led	led	O	O	O	O
to	to	O	O	O	O
significant	significant	O	O	O	O
increases	increases	O	O	O	O
in	in	O	O	O	O
PRL	prl	O	O	OTHERS	I
secretion	secretion	O	O	O	O
,	,	O	O	O	O
acting	acting	O	O	O	O
preferentially	preferentially	O	O	O	O
on	on	O	O	O	O
tonic	tonic	O	O	O	O
secretion	secretion	O	O	O	O
as	as	O	O	O	O
pulse	pulse	O	O	O	O
amplitude	amplitude	O	O	O	O
and	and	O	O	O	O
frequency	frequency	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
differ	differ	O	O	O	O
significantly	significantly	O	O	O	O
from	from	O	O	O	O
corresponding	corresponding	O	O	O	O
control	control	O	O	O	O
values	values	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
the	the	O	O	O	O
night	night	O	O	O	O
clomipramine	clomipramine	CHEMICALS	O	OTHERS	I
ingestion	ingestion	O	O	O	O
altered	altered	O	O	O	O
the	the	O	O	O	O
complete	complete	O	O	O	O
sleep	sleep	O	O	O	O
architecture	architecture	O	O	O	O
in	in	O	O	O	O
that	that	O	O	O	O
it	it	O	O	O	O
suppressed	suppressed	O	O	O	O
REM	rem	O	O	O	O
sleep	sleep	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
sleep	sleep	O	O	O	O
cycles	cycles	O	O	O	O
and	and	O	O	O	O
induced	induced	O	O	O	O
increased	increased	O	O	O	O
wakefulness	wakefulness	O	O	O	O
.	.	O	O	O	O

As	as	O	O	O	O
the	the	O	O	O	O
relative	relative	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
PRL	prl	O	O	OTHERS	I
secretion	secretion	O	O	O	O
expressed	expressed	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
percentage	percentage	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
mean	mean	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
significantly	significantly	O	O	O	O
differ	differ	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
night	night	O	O	O	O
and	and	O	O	O	O
day	day	O	O	O	O
time	time	O	O	O	O
studies	studies	O	O	O	O
(	(	O	O	O	O
46	46	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
19	19	O	O	O	O
%	%	O	O	O	O
vs	vs	O	O	O	O
34	34	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
10	10	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
it	it	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
observed	observed	O	O	O	O
sleep	sleep	O	O	OTHERS	I
disturbance	disturbance	O	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
interfere	interfere	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
action	action	O	O	O	O
per	per	O	O	O	O
se	se	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
REM	rem	O	O	O	O
sleep	sleep	O	O	O	O
was	was	O	O	O	O
shown	shown	O	O	O	O
not	not	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
determining	determining	O	O	O	O
factor	factor	O	O	O	O
either	either	O	O	O	O
for	for	O	O	O	O
secretory	secretory	O	O	O	O
pulse	pulse	O	O	O	O
amplitude	amplitude	O	O	O	O
and	and	O	O	O	O
frequency	frequency	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
,	,	O	O	O	O
for	for	O	O	O	O
both	both	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
nocturnal	nocturnal	O	O	O	O
values	values	O	O	O	O
were	were	O	O	O	O
similar	similar	O	O	O	O
with	with	O	O	O	O
and	and	O	O	O	O
without	without	O	O	O	O
prior	prior	O	O	O	O
clomipramine	clomipramine	CHEMICALS	O	OTHERS	I
ingestion	ingestion	O	O	O	O
.	.	O	O	O	O

